Does CLADRIBINE Cause Basal cell carcinoma? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Basal cell carcinoma have been filed in association with CLADRIBINE (Cladribine). This represents 0.3% of all adverse event reports for CLADRIBINE.
25
Reports of Basal cell carcinoma with CLADRIBINE
0.3%
of all CLADRIBINE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Basal cell carcinoma From CLADRIBINE?
Of the 25 reports, 1 (4.0%) resulted in death, 2 (8.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLADRIBINE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does CLADRIBINE Cause?
Fatigue (696)
Headache (579)
Lymphocyte count decreased (448)
Multiple sclerosis relapse (404)
Nausea (354)
Pneumonia (318)
White blood cell count decreased (311)
Urinary tract infection (242)
Pyrexia (207)
Multiple sclerosis (206)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which CLADRIBINE Alternatives Have Lower Basal cell carcinoma Risk?
CLADRIBINE vs CLARAVIS
CLADRIBINE vs CLARITHROMYCIN
CLADRIBINE vs CLARITIN
CLADRIBINE vs CLARITIN CHEWABLE
CLADRIBINE vs CLARITIN-D-12